Ken-ichi Kitazoe

641 total citations
13 papers, 484 citations indexed

About

Ken-ichi Kitazoe is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Ken-ichi Kitazoe has authored 13 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hematology. Recurrent topics in Ken-ichi Kitazoe's work include Bone health and treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Peptidase Inhibition and Analysis (3 papers). Ken-ichi Kitazoe is often cited by papers focused on Bone health and treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Peptidase Inhibition and Analysis (3 papers). Ken-ichi Kitazoe collaborates with scholars based in Japan and United States. Ken-ichi Kitazoe's co-authors include Toshio Matsumoto, Toshihiro Hashimoto, Masahiro Abe, Shuji Ozaki, Shinsuke Kido, Yoïchi Tanaka, Jin Asano, Hironobu Shibata, Daisuke Inoue and Etsuko Sekimoto and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Hematology.

In The Last Decade

Ken-ichi Kitazoe

11 papers receiving 473 citations

Peers

Ken-ichi Kitazoe
Kausar J. Jabbar United States
Sabrin Tahri Netherlands
Jeffrey Keats United States
Ryan M. Carr United States
Ken-ichi Kitazoe
Citations per year, relative to Ken-ichi Kitazoe Ken-ichi Kitazoe (= 1×) peers Philippe Dessauw

Countries citing papers authored by Ken-ichi Kitazoe

Since Specialization
Citations

This map shows the geographic impact of Ken-ichi Kitazoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken-ichi Kitazoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken-ichi Kitazoe more than expected).

Fields of papers citing papers by Ken-ichi Kitazoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken-ichi Kitazoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken-ichi Kitazoe. The network helps show where Ken-ichi Kitazoe may publish in the future.

Co-authorship network of co-authors of Ken-ichi Kitazoe

This figure shows the co-authorship network connecting the top 25 collaborators of Ken-ichi Kitazoe. A scholar is included among the top collaborators of Ken-ichi Kitazoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken-ichi Kitazoe. Ken-ichi Kitazoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yamaguchi, Hiroshi, et al.. (2016). A Case of Thyroid Crisis With Worsening Jaundice Despite Improvements in Heart Failure. Journal of Endocrinology and Metabolism. 6(2). 59–63. 3 indexed citations
2.
Kitazoe, Ken-ichi, Masahiro Abe, Masahiro Hiasa, et al.. (2008). Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma. International Journal of Hematology. 89(1). 45–57. 25 indexed citations
3.
Ozaki, Shuji, Osamu Tanaka, Shiro Fujii, et al.. (2007). Therapy with Bortezomib plus Dexamethasone Induces Osteoblast Activation in Responsive Patients with Multiple Myeloma. International Journal of Hematology. 86(2). 180–185. 42 indexed citations
4.
Tanaka, Yoïchi, Masahiro Abe, Masahiro Hiasa, et al.. (2007). Myeloma Cell-Osteoclast Interaction Enhances Angiogenesis Together with Bone Resorption: A Role for Vascular Endothelial Cell Growth Factor and Osteopontin. Clinical Cancer Research. 13(3). 816–823. 129 indexed citations
5.
Takeuchi, Kyoko, Masahiro Abe, Asuka Oda, et al.. (2006). SB431542, a TGF-Beta Receptor Kinase Inhibitor, Restores Bone Formation Which Ameliorates Myeloma-Induced Microenvironment.. Blood. 108(11). 3479–3479. 2 indexed citations
6.
Kitazoe, Ken-ichi, Masahiro Abe, Kumiko Kagawa, et al.. (2006). Emerging of Valproic Acid as an Anti-Myeloma Agent.. Blood. 108(11). 3482–3482. 1 indexed citations
7.
Oshima, Takashi, Masahiro Abe, Jin Asano, et al.. (2005). Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2. Blood. 106(9). 3160–3165. 256 indexed citations
8.
Shibata, Hironobu, Masahiro Abe, Kenji Hiura, et al.. (2005). Malignant B-Lymphoid Cells with Bone Lesions Express Receptor Activator of Nuclear Factor-κB Ligand and Vascular Endothelial Growth Factor to Enhance Osteoclastogenesis. Clinical Cancer Research. 11(17). 6109–6115. 16 indexed citations
9.
Ozaki, Shuji, Etsuko Sekimoto, Yoichi Tanaka, et al.. (2005). Anti-Myeloma Activity of the Maytansinoid Immunoconjugate of Internalizing Human Monoclonal Antibody Specific for HM1.24/BST2 (CD317).. Blood. 106(11). 3388–3388. 1 indexed citations
10.
Oshima, Takashi, Masahiro Abe, Jin Asano, et al.. (2004). Myeloma Cells Suppress Osteoblast Differentiation by Secreting a Soluble Wnt Inhibitor, sFRP-2.. Blood. 104(11). 2356–2356. 6 indexed citations
11.
Watanabe, Hirofumi, et al.. (1999). Anti-HPA-5a antibody as a possible cause of platelet transfusion refractoriness in a patient with acute myelogenous leukemia.. Journal of the Japan Society of Blood Transfusion. 45(1). 32–37.
12.
Yoshida, Takashi, Hironori Aoki, Yasumasa Ikeda, et al.. (1998). [An autopsy case of primary squamous cell carcinoma of the liver associated with hepatitis C virus antibody positive liver cirrhosis].. PubMed. 95(10). 1141–6. 1 indexed citations
13.
Kitazoe, Ken-ichi, et al.. (1998). A CASE OF LIPOMA DERIVED FROM THE MUSCLE LAYER OF THE TERMINAL ILEUM. 40(3). 572–578. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026